(Press-News.org) Researchers from Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs chronological lifespan.
The new study, published in Communications Biology journal by Juhi Kumar, Kristal Ng and Charalampos Rallis, sheds light on how drugs and natural metabolites can influence lifespan through the Target of Rapamycin (TOR) pathway.
TOR is a conserved signalling pathway active in humans as well as yeast. It is a central regulator of growth and ageing fundamental in age-related diseases such as cancer and neurodegeneration and is already a major focus of anti-ageing and cancer research, with drugs such as rapamycin showing promise in extending healthy lifespan in animals.
Rapalink-1, the new drug studied by the team, is a next-generation TOR inhibitor currently under investigation for cancer therapy. The researchers found that rapalink-1 not only slowed aspects of yeast cell growth but also significantly extended lifespan, working through TORC1 — the growth-promoting arm of the TOR pathway.
Unexpectedly, the study revealed a key role for a set of enzymes called agmatinases, which break down the metabolite agmatine into polyamines. These enzymes act as part of a previously unknown “metabolic feedback loop” that keeps TOR activity in check. When agmatinase function was lost, cells grew faster but aged prematurely — highlighting a trade-off between short-term growth and long-term survival. Supplementing yeast with agmatine or putrescine, the compounds linked to this pathway, also promoted longevity and benefited cells under certain conditions.
“By showing that agmatinases are essential for healthy ageing, we’ve uncovered a new layer of metabolic control over TOR — one that may be conserved in humans,” said Dr. Rallis. “Because agmatine is produced by diet and gut microbes, this work may help explain how nutrition and the microbiome influence ageing.”
Rallis acknowledges that agmatine supplements are available in the market, but stresses: “We should be cautious about consuming agmatine for growth or longevity purposes. Our data indicate the agmatine supplementation can be beneficial for growth only when certain metabolic pathways related to arginine breakdown are intact. In addition, agmatine does not always promote beneficial effects as it can contribute to certain pathologies”.
The findings have broad implications for healthy ageing research, cancer biology, and metabolic disease, pointing to new strategies that combine TOR-targeting drugs with dietary or microbial interventions.
ENDS
This press release is based on the paper ‘Rapalink-1 reveals TOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating TOR activity and lifespan in fission yeast’ published in Communications Biology.
DOI: 10.1038/s42003-025-08731-3
URL: https://www.nature.com/articles/s42003-025-08731-3
For more information on this release, to receive a copy of the paper or to speak with Dr Charalampos Rallis, please contact Katy Taylor-Gooby at Queen Mary University of London at k.taylor-gooby@qmul.ac.uk
END
New drug and enzyme class found to have anti-ageing properties
Researchers from Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs chronological lifespan.
2025-09-29
ELSE PRESS RELEASES FROM THIS DATE:
New tool identifies proteins that control gene activity
2025-09-29
A new tool greatly improves scientists’ ability to identify and study proteins that regulate gene activity in cells, according to research led by Weill Cornell Medicine investigators. The technology should enable and enhance investigations in both fundamental biology and disease research.
The activity of a gene is often regulated—switched on, sped up, slowed down, switched off—by one or more proteins that bind to DNA to exert their effect. However, identifying these DNA-binding proteins has been challenging due to the lack of a precise method. In their study, reported Sept. 29 in the Proceedings of the National Academy of Sciences, the researchers developed a ...
New study reveals why nature picked today’s proteins
2025-09-29
Why did life on Earth choose alpha amino acids as the building blocks of proteins? A new study suggests the answer lies in the stability of their inter-molecular interactions. Researchers found that primitive peptide-like molecules made from alpha backbones formed more durable, compartment-like structures than their longer beta counterparts, giving them a potential evolutionary advantage. The findings propose an assembly-driven model for the origins of life, offering fresh insight into how chemistry shaped biology.
A new study from the Hebrew University of Jerusalem sheds light on one of life’s greatest mysteries: ...
The first animals on Earth may have been sea sponges, study suggests
2025-09-29
A team of MIT geochemists has unearthed new evidence in very old rocks suggesting that some of the first animals on Earth were likely ancestors of the modern sea sponge.
In a study appearing today in the Proceedings of the National Academy of Sciences, the researchers report that they have identified “chemical fossils” that may have been left by ancient sponges in rocks that are more than 541 million years old. A chemical fossil is a remnant of a biomolecule that originated from a living organism that has since been buried, transformed, and preserved in sediment, sometimes for hundreds of millions of years.
The newly identified chemical fossils are special types ...
Scientists map the navigation styles of wild cats and dogs
2025-09-29
The next time you watch your dog visit the same places around your yard or notice that your cat seems to explore a new area every time it ventures outside, consider this: you might be witnessing an ancient evolutionary strategy in action.
A new study published in the Proceedings of the National Academy of Sciences during the week of September 29, 2025 reveals that wild canids have, on average, both a greater density of travel routeways and a greater probability of routeway usage than wild felids. Led by University of Maryland researchers, the ...
Polyphenols Applications World Congress and Iprona will launch Global Call to Advance Robust, Reproducible Polyphenol Research, next October in Malta
2025-09-29
At the 18th World Congress on Polyphenols Applications, which will be held in Malta on October 2-3, 2025, Iprona and Polyphenols Applications will announce a global call to action, inviting researchers to strengthen the quality and reproducibility of polyphenol science.
Through this initiative, ElderCraft®, a polyphenol-standardised European black elderberry (Sambucus nigra) water extract, is now available at no cost to qualified academic and clinical research groups worldwide.
ElderCraft® is a polyphenol and anthocyanin-rich extract, sourced exclusively from ...
Adaptive radiation therapy increases safety and preserves quality of life, says study
2025-09-29
For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or enmeshed within the bowel. Given their radioresistant nature they require high doses of radiation that risk damaging healthy nearby tissue. Once patients have undergone an initial radiation course, doctors are often left with no safe radiation treatment option.
But a pilot study from Fox Chase Cancer Center, presented at the 2025 American ...
Electric space heating, appliances reduce US residential energy consumption
2025-09-29
UNIVERSITY PARK, Pa. — Electric space heating systems and appliances like water heaters can help American homeowners reduce their energy use, and possibly their utility bills, according to a team led by researchers at Penn State.
The researchers set out to identify the most important factors driving U.S. on-site residential energy consumption, which the team said accounts for approximately 21% of primary energy consumption in the country and is more complex than commercial energy use. They found that electric heating systems like heat pumps, compared to systems that rely on natural gas and oil, had the largest impact on reducing on-site energy ...
Could your next job interview be with a chatbot? New study seeks to help bring fairness into AI-powered hiring
2025-09-29
Landing a job traditionally meant polishing a resume, printing extra copies and sitting across from a hiring manager. Today, the first “person” to evaluate you might not be a person at all — it could be a chatbot powered by artificial intelligence. These automated systems can ask questions, score responses and even recommend who gets hired.
Rice University’s Tianjun Sun has received a National Science Foundation award to lead a two-year collaborative project with the University of Florida examining how AI interview systems work — and how to make them more fair.
For employers, chatbot interviews promise consistency ...
Intensity-modulated radiation therapy (IMRT) matches proton therapy in patient-reported outcomes for oropharyngeal cancer
2025-09-29
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people with locally advanced oropharyngeal cancer. The TORPEdO trial, a randomized study conducted across the United Kingdom, found no meaningful differences between the treatments in patient-reported quality of life, swallowing function or feeding tube dependence at one year.
Both advanced radiation approaches resulted in excellent ...
Radiation therapy after surgery safely reduces pelvic relapse risk from locally advanced, muscle-invasive bladder cancer
2025-09-29
SAN FRANCISCO, September 29, 2025 — Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial. In the study, moderate doses of radiation therapy after bladder removal surgery sharply cut the rates of cancer returning in the pelvis without adding serious side effects. Findings of the Bladder Adjuvant RadioTherapy (BART) trial conducted at centers across India will be presented today at the American Society ...
LAST 30 PRESS RELEASES:
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
Dose of psilocybin, dash of rabies point to treatment for depression
Helping health care providers navigate social, political, and legal barriers to patient care
[Press-News.org] New drug and enzyme class found to have anti-ageing propertiesResearchers from Queen Mary University of London’s School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs chronological lifespan.